Skip to main content
. 2021 May 26;13(11):2603. doi: 10.3390/cancers13112603

Figure 1.

Figure 1

Chest CT-scan with intravenous (IV) contrast showing a stage IIIA NSCLC of 42 mm × 35 mm in the right upper lobe pre-induction therapy with a volume reduction after 4 cycles of neoadjuvant cisplatinum/pemetrexed + nivolumab (27 mm × 22 mm) ((A,B): mediastinal window; (C,D): lung window).